BIOMAT Database Logo BIOMAT Database Logo

Infection with human immunodeficiency virus type 1 among leprosy patients in Zaire. 1995

S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015023 Democratic Republic of the Congo A republic in central Africa, east of the REPUBLIC OF THE CONGO, south of the CENTRAL AFRICAN REPUBLIC and north of ANGOLA and ZAMBIA. The capital is Kinshasa. Belgian Congo,Congo (Kinshasa),Katanga,Zaire
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015492 AIDS Serodiagnosis Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX. AIDS Serology,HIV Serodiagnosis,HTLV-III Serodiagnosis,HTLV-III Serology,Serodiagnosis, AIDS,Serodiagnosis, HIV,Serodiagnosis, HTLV-III,Serology, AIDS,Serology, HTLV-III,AIDS Serodiagnoses,HIV Serodiagnoses,HTLV III Serodiagnosis,HTLV III Serology,HTLV-III Serodiagnoses,Serodiagnoses, AIDS,Serodiagnoses, HIV,Serodiagnoses, HTLV-III,Serodiagnosis, HTLV III,Serology, HTLV III
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire.
January 1989, Journal of acquired immune deficiency syndromes,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Risk of human immunodeficiency virus infection among Peace Corps volunteers in Zaire.
September 1992, Archives of internal medicine,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.
July 1993, AIDS research and human retroviruses,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Natural history of human immunodeficiency virus infection in Zaire.
September 1986, Lancet (London, England),
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan.
November 2007, Japanese journal of infectious diseases,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Luetic cervical adenitis in patients with human immunodeficiency virus type 1 infection.
July 1992, Archives of otolaryngology--head & neck surgery,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Primary human immunodeficiency virus type 1 infection.
June 2005, Current HIV/AIDS reports,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Acute human immunodeficiency virus type 1 infection.
July 1998, The New England journal of medicine,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Inflammasomes in Human Immunodeficiency Virus Type 1 Infection.
October 2022, Infectious diseases & immunity,
S B Lucas, and P E Fine, and J A Sterne, and J M Pönnighaus, and A C Turner, and K M De Cock, and M Zuckerman
Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection.
January 2018, Medicine,
Copied contents to your clipboard!